Dr. Scanlon is a trained Molecular Biologist with a research focus in cancer and gene therapy. Dr.
Scanlon’s notable academic achievements include: Leukemia Society Scholar,


Dr. Scanlon was a senior executive in a German Pharmaceutical Company, Schering AG (Berlin, Germany). He was responsible for the genomic and cancer programs in the US, Europe and Asia.He has also been CEO


For the past 15 years, Dr. Scanlon has been involved with the angel investment community on both the west coast and east coast. He has been Chairman of the Pasadena Angels with ~100 investors and an executive member